Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagun Parakh

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 2, 2016
Novel Approaches To Undergraduate Oncology EducationFrancis J Ha, Sagun Parakh
Neuro-Oncology Practice|May 23, 2022
Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settingsSagun Parakh, Hui K Gan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Isolated Hypogonadotropic Hypogonadism Secondary to Anti-Programmed Death Ligand 1 InhibitorAmy Davies, Negar Naderpoor, Sagun Parakh
The Oncologist|April 19, 2018
Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 TherapySagun Parakh, Jonathan Cebon, Oliver Klein
Cancers|December 24, 2021
Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic OpportunitiesSagun Parakh, Matthias Ernst, Ashleigh R Poh
The Medical Journal of Australia|March 24, 2022
Lung cancer in non-smokers: a diagnosis of increasing importanceSamantha Dean, Rachel Lennox, Clare Senko, et al.
Asian Journal of Surgery|June 28, 2015
Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findingsSagun Parakh, Sivakumar Gananadha, Robert Allen, et al.
Critical Reviews in Oncogenesis|January 19, 2021
Sensitization of Cancers Resistant to HER2 AntibodiesSagun Parakh, Hui K Gan, Andrew M Scott
Journal of Clinical Pharmacology|April 21, 2016
Temozolomide-Associated Liver FibrosisSagun Parakh, Anis Hamid, Lawrence Cher, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Antibody-drug conjugates: beyond current approvals and potential future strategiesSiddharth Menon, Sagun Parakh, Andrew M Scott, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 2, 2016
Novel Approaches To Undergraduate Oncology EducationFrancis J Ha, Sagun Parakh
Neuro-Oncology Practice|May 23, 2022
Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settingsSagun Parakh, Hui K Gan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Isolated Hypogonadotropic Hypogonadism Secondary to Anti-Programmed Death Ligand 1 InhibitorAmy Davies, Negar Naderpoor, Sagun Parakh
The Oncologist|April 19, 2018
Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 TherapySagun Parakh, Jonathan Cebon, Oliver Klein
Cancers|December 24, 2021
Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic OpportunitiesSagun Parakh, Matthias Ernst, Ashleigh R Poh
The Medical Journal of Australia|March 24, 2022
Lung cancer in non-smokers: a diagnosis of increasing importanceSamantha Dean, Rachel Lennox, Clare Senko, et al.
Asian Journal of Surgery|June 28, 2015
Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findingsSagun Parakh, Sivakumar Gananadha, Robert Allen, et al.
Critical Reviews in Oncogenesis|January 19, 2021
Sensitization of Cancers Resistant to HER2 AntibodiesSagun Parakh, Hui K Gan, Andrew M Scott
Journal of Clinical Pharmacology|April 21, 2016
Temozolomide-Associated Liver FibrosisSagun Parakh, Anis Hamid, Lawrence Cher, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Antibody-drug conjugates: beyond current approvals and potential future strategiesSiddharth Menon, Sagun Parakh, Andrew M Scott, et al.
Pageof 8